Maslan Andrew Scott 4
4 · CYTOMEDIX INC · Filed Feb 14, 2012
Insider Transaction Report
Form 4
CYTOMEDIX INCCMXI
Maslan Andrew Scott
Chief Financial Officer
Transactions
- Exercise of In-Money
Common Stock
2012-02-13$0.54/sh+8,961$4,810→ 97,780 total - Exercise of In-Money
Warrant
2012-02-13−8,961→ 477,321 totalExp: 2015-04-09→ Common Stock (8,961 underlying)
Footnotes (1)
- [F1]Represents shares of common stock of the Company issued upon exercise of an in-the-money warrant purchased in the April 2010 private placement of the Company's securities. The exercise price per share of such warrant is $0.5368. The warrant is exercisable immediately and expires on April 9, 2015.